Plasma lipoproteins consist of water-soluble complexes composed of a lipid core surrounded by surface phospholipids and apoproteins and are primarily responsible for transporting lipids such as triglycerides and cholesteryl esters to the various organs and tissues of the body. While extensive research has been performed dealing with serum albumin and its role in the transport of numerous endogenous and exogenous compounds (Kragh-Hansen, 1981) , few studies have examined the role of plasma lipoproteins in the transport and delivery of foreign compounds. Nonetheless, the possible importance of lipoprotein binding or interaction with certain lipophilic compounds has been recognized. For example, recent studies have indicated that the interaction between lipoproteins and a variety of lipophilic com- (Klausner et al., 1975) , benzo [a] pyrene (Shu and Nichols, 1979, 198 1; Busbee et al., 1982) , polychlorinated biphenyls (Becker and Gamble, 1982) , and chloroethylnitrosoureas (Weinkom et al., 1980) ] involves partitioning of these lipophilic agents into the hydrophobic core of lipoproteins. Furthermore, Marinovich et al. (1983) have proposed that the binding of 2, 3,7,8-tetrachlorodibenzodioxin (TCDD) to plasma lipoproteins may actually delay the toxicity of this agent in experimental hyperlipidemia. It is these and similar observations that have lead to the possibility that plasma lipoproteins may play a significant role in the transport of nonpolar, lipophilic compounds.
The involvement of lipoproteins in pharmacokinetics becomes even more pertinent in light of recent findings (Brown and Goldstein, 1976; Brown et al., 1981) that indicate that these macromolecular complexes are taken up into specific cells by receptor-mediated processes. This process, first described in human fibroblasts, involves the binding of low density lipoproteins (LDL) to specialized membrane receptors. This specific binding to the receptor is transferred through the recognition apoproteins located on the surface of LDL. Once binding has occurred, the LDL-receptor complex is rapidly internalized by endocytosis. The importance of the various apoproteins in mediating the specific binding of lipoproteins has been demonstrated by chemically modifying the lysine residues of the lipoproteins by acetylation with diketene or acetic anhydride (Weisgraber et al., 1978) .
Such modification has been shown to abolish LDL binding and uptake via this specific receptor-mediated process. According to currrent concepts, tissues responsible for the biosynthesis of steroid hormones derive their cholesterol from three possible sources, namely, (1) circulating plasma lipoproteins, (2) hydrolysis of intracellular cholesteryl esters, and (3) intracellular biosynthesis.
In man, LDL are the major carrier of plasma cholesterol to extrahepatic tissues. However, studies with rats indicate that the adrenal cortex relies mainly upon circulating high density lipoproteins (HDL) as the source of cholesterol (Anderson and Dietschy, 1978; Carr et al., 1980; Faust et al., 1977; Balasubramaniam et al., 1977b) .
Once this source becomes depleted, as occurs upon treatment of rats with 4-aminopyrazolo[3,4-dlpyrimidine (CAPP), the adrenal gland increases the number of lipoprotein surface receptors, allowing increased uptake of the remaining circulating lipoproteins. Furthermore, intracellular cholesterol biosynthesis as well as hydrolysis of intracellular cholesteryl esters increases.
Utilizing the above information, this project was developed to study the role of lipoproteins in the transport and delivery of foreign molecules to the adrenal gland. Two radioiodinated tracers were selected for this study. One was a radioiodinated analog of mitotane (o,p'-DDD) a drug which markedly affects adrenal function and is used clinically to treat adrenal carcinoma, and the other was a radioiodinated analog of cholesteryl oleate, a normal constituent of the lipophilic core of lipoproteins (Fig. 1) utilized to study the role of lipoproteins in drug disposition, in general, and transport to the adrenal, specifically, by incorporating these probes into rat HDL prior to their administration to normal rats or to rats made hypolipidemic by treatment with 4-APP.
METHODS
Animals.
Female Sprague-Dawley rats (Spartan Research Animals, Inc.) weighing 200 to 260 g were used in all experiments. The rats were housed in temperatureand light-controlled quarters and had free access to feed (Teklad 4% rat and mouse diet) and water. 1-(2-Chlorophenyl)-I-(4-iodophenyl)-2,2dichIoroethane (I-DDD) was radioiodinated (rZ51-DDD) as described previously (CounselI et al., 1967) , except for the use of the acetamide melt procedure (Seevers and Counsell, 1982) for the exchange reaction. Radiochemical purity was determined by thin-layer chromatography (TLC) using silica gel plates (Eastman Kodak) developed in hexane: I-butanol:acetic acid (85:5: 10 v/v). Stable I-DDD standard was visualized by uv light, and the plate was scanned for radioactivity using a Berthold radiochromatogram scanner, Model LB2723. This analysis revealed a single radioactive peak coincident with the standard.
Radioiodinated cholesteryl
oleate. [ 1 9-'251]Iodocholesteryl oleate ('251-CO) was prepared as previously described (Nordblom et al., 1980) and stored as an oil at 0°C until used. Radiochemical purity was determined by TLC as described above in the solvent system of txmzene:ethyl acetate (9: 1 v/v). The plates were developed in iodine vapor and scanned for radioactivity as previously described. In ah analyses, the single radioactive peak was coincident with the standard visualized with iodine vapor.
In vitro preparation of HDL labeled with lz51-DDD ("'I-DDD-HDL).
Rat HDL were isolated from plasma according to the method of Have1 et al. (1955) . Very low density lipoproteins (VLDL) and LDL were first isolated in one fraction by adjusting the density of plasma to 1.070 with RBr and centrifuging for 20 hr at 100,OOOg. HDL were then isolated by adjusting the density of the remaining solution to 1.2 10 with KBr and centrifuging for 45 hr at 100,OOOg. The isolated HDL were then dialyzed overnight against 4 liters of 5 mM Tris buffer with 1 mM EDTA at pH 7.4, to remove the high concentration of salt. Purity of the isolated HDL was verified by polyacrylamide gel electrophoresis (PAGE) analysis (see below). Protein concentration of isolated HDL was determined following the modified Lowry procedure of Markwell et al. (I 978). 1251-DDD was allowed to interact with HDL in a manner similar to that described by Shu and Nichols (1979) . '251-DDD (391.0 &i, 2.58 rmol) previously immobilized on glass beads was incubated with a 4.5-ml sample of HDL (19.8 mg protein) for I hr at 37°C. A subsequent experiment indicated that maximum uptake of compound from glass beads into HDL solution OCcurred at 1 hr (74% uptake) when compared to a control solution of saline (~3% uptake).
After incubation, the radioiodinated HDL were then subjected to PAGE analysis and lipid extraction-TLC (see below) to assure the integrity of both the HDL and tracer.
In vivo preparation of HDL labeled with '251-CO('z51-CO-HDL).
Donor rats received iv injections of '25I-CO (1.2 to 1.4 mCi, 2.30 pmol) via the tail vein in 2.0 to 2.5 ml of vehicle (see below for formulation). At 0.5 hr following injection, the rats were killed by exsanguination from the heart while under diethyl ether anesthesia. The blood was collected in heparinized Vacutainer tubes and centrifuged at low speed for 10 min to obtain plasma. Plasma from five rats was pooled (total volume, 9.0 ml), and the denisity was adjusted to 1.070 with KBr as described above. After ulracentrifugation at 100,OOOg for 20 hr at 15°C the top 2.0 ml (containing CM, VLDL, and LDL) was removed as previously described. The remaining infranate was used at '251-CO-HDL. In a preliminary tissue distribution study, '*'I-CO-HDL obtained in this manner was compared to an HDL preparation that was further purified by ultracentrifugation as described above. Since there was no major difference in the tissue distribution profiles of these two preparations (results not shown), the second centrifugation step was omitted in subsequent preparations. This HDL preparation was then anaylyzed following the procedures described below.
Modification of HDL labeled with '2sI-C0. Chemical modification of the surface apoproteins of lipoproteins has been shown to prevent recognition by lipoprotein receptors (Weisgraber et al., 1978) . To determine if the uptake of HDL labeled with '25I-CO into the adrenal was via a receptor-mediated process, HDL were modified with acetic anhydride following the procedure of Basu et al. (1976) . Furthermore, by saturating the surface apoproteins with stable o,p'-DDD, one might also observe a decrease in the adrenal uptake of 'r51-CO-HDL. Acetylated HDL were prepared by reacting the free amino groups of the lipoprotein with acetic anhydride, which increased the net negative charge of the lipoprotein particle. In a typical preparation, 80 pl of a saturated solution of sodium acetate was added to 0.15 M NaCl (0.5 to 1.0 ml) containing 0.25 to 0.5 mg HDL protein with continuous stirring in an ice-water bath. Next, acetic anhydride was added in multiple small aliquots (0.2 ~1) over a period of 1 hr with continuous stirring. After the addition of a total mass of acetic anhydride equal to 1.5 times the mass of protein used, the mixture was stirred for an additional 30 min. The reaction mixture was then dialyzed overnight at 4°C against 4 liters of buffer containing 5 mM Tris and 1 mM EDTA at pH 7.4. Narayan (1975) . Gels consisted of 3.5 cm of 3.75% (w/ v) main gel and I .O cm of 2.5% (w/v) large-pore stacking gel. A 50-~1 aliquot of the fraction was mixed with 25 ~1 of Sudan black dye (a lipoprotein prestain) for 1 hr and 25 *I of the mixture was applied to the top of the stacking gel. The gels were run at 2.5 mA/tube until the leading band migrated 1.7 cm into the main gel. The gels were sliced into regions corresponding to lipoprotein bands as described by Narayan ( 1975) : region 1, stacking gel CM; region 2, main gel VLDL/LDL, region 3, main gel HDL, region 4, main gel albumin; and region 5, main gel area below albumin.
The regions were assayed for radioactivity in a well counter. Additionally, to ascertain the stability of "'1-DDD and '251-C0 under the conditions of lipoprotein incorporation, 0. I-ml aliquots of "'1-DDD-HDL were mixed with 0.4 ml distilled water and extracted with chlorofotmmethanol (2: 1, v/v) as described by Folch et al. (1957) (Shiff et al.. 1971; Balasubramaniam et al.. 1977a) . The dose was 40 mg/kg body weight per day for 3 days.
Tissue distribution of radioactivity after administration of "'I-DDD, "'I-DDD-HDL, "'I-CO, or "'I-CO-HDL to normal and hypolipidemic rats. Groups of normal and 4-APP-treated rats each received 0.5 ml of '*'I-DDD, '251-DDD-HDL, "'I-CO, or '251-CO-HDL. The amount of radioactivity administered to each group was as follows: (1) "'1-DDD in 2% BSA vehicle, normal (12.1 &i, 0.27 rmol). 4-APP treated (7.6 rCi, 0.15 pmol): (2) lz51-DDD-HDL, normal (6.6 &i), 4-APP treated (6.6 &i); (3) '251-C0 in Tween-saline vehicle, normal ( 13.6 PCi, 0.18 rmol), 4-APP treated ( 11.9 rCi, 0.04 pmol); (4) '251-CO-HDL, normal (7.5 rCi), 4-APP treated (0.9 PCi). At least three animals were used in each group, and animals were killed at 5, 15. 30, and 60 min after injection by exsanguination from the heart. The blood was collected in heparinized Vacutainer tubes. Samples of whole blood were taken for counting, and the remaining blood centrifuged at low speed for 10 min to obtain plasma. The following organs were removed, rinsed of blood. and blotted dry: adrenal cortex, liver, ovaries, and thyroid.
Large organs were minced with scissors. Samples were transferred to tared cellulose acetate capsules, weighed, and placed in polystyrene gamma tubes. Aliquots of plasma from all rats were analyzed by PAGE analysis as described above. Statistical analysis of the data were performed utilizing Student's t test.
Measurement of in vitro transfer of radioiodinated probes from HDL following incubation with plasma components.
To examine the stability of the association of lZ51-DDD and '251-C0 with HDL, '251-DDD-HDL and '251-CO-HDL were incubated with plasma. A 0.5-ml aliquot of lz51-DDD-HDL (10.9 PCi) was incubated with 6.0 ml rat plasma at 37°C in a water bath with agitation. At 5, 15, 30, and 60 mitt, 25-~1 aliquots of the incubation medium were taken and analyzed by PAGE as previously described.
Since the '251-CO-HDL preparation contained all of the plasma components except the VLDL/LDL fraction which had previously been removed, '251-CO-HDL was incubated with rat lipoproteins of density < 1.070 (VLDL + LDL). This incubation medium contained essentially the reconstituted components of rat plasma. Rat hpoproteins of density < 1.070 were isolated as previously described. A 2.0-ml aliquot of this fraction was incubated with 0.5 ml of the '251-CG-HDL preparation as described above. At 0.5, 1, 3, and 24 hr, 25-~1 ahquots of the incubation medium were analyzed as mentioned above. Tissue distribution of radioactivity afier administration of modified HDL labeled with "'I-CO to normal and hypolipidemic rats. Groups of rats treated with 4-APP received 0.3 ml of acetyl-'251-CO-HDL or DDD-lz51-CO-HDL.
Animals received either 2.0 &i of acetyl-'251-CO-HDL or 1.6 &i of DDD-'?-CO-HDL. Three animals were used in each of the 4-APP-treated groups. Animals were killed at 15 min after injection by exsanguination from the heart. The tissue distribution of these modified HDL preparations was performed as described above. Statistical analysis of the data was performed utilizing Student's t test.
RESULTS

Administration
of 1251-C0 to donor rats resulted in the appearance of approximately 5% of the dose in the HDL fraction within 0.5 hr. Ultracentrifugal separation gave an HDL fraction which upon gel electrophoresis showed the majority of radioactivity (>91%) to be associated with the HDL region. Moreover, lipid extraction of this HDL fraction and subsequent TLC analysis revealed that over 90% of the radioactivity remained associated with 1251-C0.
The tissue distribution profile of '251-C0 and '251-CO-HDL is illustrated in Fig. 2 . The uptake of radioactivity into the adrenal cortex significantly increased with both normal and hypolipidemic animals when HDL were labeled with '251-C0. In untreated animals there was a 4-fold increase in the adrenal uptake following administration of 1251-CO-HDL, as compared to '251-C0 in a Tweensaline vehicle. However, in 4-APP-treated animals, there was a 27-fold increase in the adrenal uptake when 1251-CO-HDL was compared to '251-C0.
Incubation of HDL with '251-DDD previously immobilized on glass beads resulted in the transfer of >77% of the initial radioactivity into the HDL phase. PAGE analysis of "'1-DDD-HDL showed that >94% of the radioactivity migrated with the HDL band. Moreover, lipid extraction of '251-DDD-HDL and subsequent TLC analysis revealed that over 95% of the radioactivity was still bound to the parent compound. cortex at this time point in both untreated and 4-APP-treated animals. It was also noted that this time period coincided with the peak concentration of radioactivity in the adrenal cortex for both preparations in normal animals. However, in hypolipidemic animals, the peak concentration of radioactivity in the adrenal cortex for both preparations was 5 min postinjection and was similar to the value obtained at 15 min in normal animals (data not shown). Furthermore, there was no significant difference in the tissue distribution for all tissues within treatment groups when 1251-DDD was administered associated with HDL or in a 2% BSA vehicle (Fig. 3 ). Since the adrenal uptake of 1251-CO-HDL was dramatically greater than that observed for '251-DDD-HDL, the stability of the association of '251-C0 and '251-DDD with HDL was examined in vivo and in vitro. PAGE analysis of '251-CO-HDL prior to administration to normal rats indicated that 88% of the radioactivity was located in the HDL region (Table 1) . Following in vivo administration of "'1-CO-HDL, a majority of the radioactivity remained with the HDL region even after 24 hr postinjection. Similar results were obtained following in vitro incubation of "'1-CO-HDL with a plasma fraction of d < 1.070 (i.e., reconstituted plasma). These data support the view that '251-C0 is tightly associated with HDL and is in all probability confined to the lipid core in a manner similar to that proposed for other cholesteryl esters.
PAGE analysis of 1251-DDD-HDL prior to administration to normal rats indicated that >94% of the radioactivity was located in the HDL region (Table 2) . However, following in vivo administration of 1251-DDD-HDL, there was a rapid redistribution of radioactivity from HDL to other plasma components. Similarly, in vitro incubation of "'1-DDD-HDL with whole rat plasma caused a rapid redistribution of radioactivity to other regions of the gel. These findings suggest that a portion of '251-DDD is associated with the surface components of HDL (i.e., apoproteins). This could account for the observed rapid exchange of '251-DDD from HDL to other plasma components.
To confirm the participation of 1251-CO-HDL in receptor-mediated uptake by the adrenal, this preparation was acetylated with al., 1978) .
As indicated in Fig. 4 , when lz51-DDD (0.01 mg) was incubated without additional stable o,p'-DDD, approximately 90% of the radioactivity was released from the glass beads into the HDL solution as compared to only approximately 10% of the radioactivity becoming soluble in saline. PAGE analysis of the HDL solution also inidicated that ~70% of the radioactivity in solution was associated with the HDL component. Furthermore, as increasing amounts of stable o,p'-DDD were added to '251-DDD, less radioactivity became associated with HDL. As indicated in Fig. 4 , HDL became completely saturated as the mass of stable o,p'-DDD approached 10 mg. At all concentrations of o,p'-DDD, < 10% of the radioactivity was released into the saline solution.
These results therefore indicate that 0.5 mg of HDL protein can become completely saturated with o,p'-DDD when incubated with 10 mg of this compound. As a result, HDL labeled with '251-C0 (0.25 mg protein) were incubated with 10 mg stable o,p'-DDD previously immobilized on glass beads as described under Methods. dioactivity into these same tissues. However, on a statistical basis the tissue uptake of DDD-'2Sl-CO-HDL was not significantly different from that of '251-CO-HDL. The observation that saturating 1251-CO-HDL with o,p'-DDD only slightly altered adrenal uptake is consistent with the rapid redistribution of 12%DDD from HDL to other plasma components. This rapid loss of u,p'-DDD from the surface of '*%CO-HDL could account for the greater adrenal uptake of radioactivity from DDD-'251-CO-HDL than observed for acetyl-'251-CO-HDL.
DISCUSSION
When 1251-CO-HDL was administered to normal rats, its specific activity was immmediately reduced by the endogenous plasma lipoproteins. This, in turn, could explain the modest increase of uptake of radioactivity by the adrenal when '251-CO-HDL was administered to normal animals. Treatment of rats with 4-APP, however, caused a profound lowering of circulating lipoprotein concentrations, thus minimizing dilution of '251-CO-HDL upon administration.
Moreover, this decrease in circulating lipoproteins could also cause an increase in the number of HDL receptors in target tissues, which is consistent with the known regulation of adrenal activity (Brown et al., 198 1; Balasubramaniam et al., 1977b; Pittman et al., 1982) . Both or either one of these possibilities could account for the dramatic increase in adrenal uptake of '251-CO-HDL in the hypolipidemic animals.
On the basis of these studies, it appears that the association of these lipophilic compounds with HDL depends upon their molecular properties. It is proposed that '251-C0 becomes incorporated into the lipophilic core of HDL and that the resulting '251-CO-labeled HDL are capable of participating in the normal receptor-mediated uptake process characteristic of the adrenal. On the other hand, the results of this study suggest that 1251-DDD associates with the surface as well as the core components of HDL. Such binding of drugs to the surface apoproteins could perturb the normal receptor-mediated uptake process.
In a preliminary experiment, the electrophoretic migration of unlabeled HDL treated with only sodium acetate was compared to HDL treated with both sodium acetate and acetic anhydride. As seen in Fig. 6 , PAGE analysis indicated that treatment of HDL with sodium acetate alone did not alter the gel migration pattern when compared to that of untreated control HDL. On the other hand, treatment of HDL with sodium acetate and acetic anhydride resulted in an altered gel migration pattern. The acetylated HDL appeared to migrate more rapidly toward the cathode, which is consistent with results obtained by Basu et al. (1976) . HDL labeled with '251-C0 were then acetylated with acetic HDL unsuccessful with patients undergoing treatment with o,p'-DDD (Gross et al., 1981) .
In conclusion, this study has shown that lipophilic compounds become associated with lipoproteins and that the nature of this association depends upon molecular properties that are not readily apparent. Lipophilic FIG. 6 . PAGE analysis of acetylated HDL was per-compounds may become incorporated into formed on (1) untreated rat HDL, (2) rat HDL treated the lipophilic core of lipoproteins and/or with sodium acetate, and (3) rat HDL treated with sodium acetate and acetic anhydride.
bind to their surface components. Moreover, compounds which become incorporated into the core of lipoproteins may participate in anhydride (acetyl-I*?-CO-HDL) and the tis-receptor-mediated uptake into tissues such sue distribution of these modified HDL was as the adrenal and thereby accumulate in compared to the tissue distribution of '*'Isuch tissues. On the other hand, drugs that CO-HDL.
PAGE analysis of 1251-CO-HDL bind to the surface apoproteins of lipoproteins incubated with acetic anhydride indicated may interfere with the normal receptor-methat the acetylated '*'I-CO-HDL (acetyl-'251-diated processes and thereby alter the meta-CO-HDL) migrated more rapidly toward the bolic fate of plasma lipoproteins.
On the cathode. Furthermore, when the gel was sliced basis of this study, the effect of lipoproteins and counted, the majority of the radioactivity on drug disposition and transport as well as was found associated with the more rapidly the effect of drugs on lipoprotein metabolism migrating band. deserves further examination. As previously indicated, results from PAGE anaylsis indicated that a significant amount of '*'I-DDD was interacting with the surface ACKNOWLEDGMENTS components of HDL. '*%DDD could be binding to the surface apoproteins of HDL for the receptor-mediated uptake of lipoproteins into sterioid-secreting tissues in the rat. Furthermore, these results suggest o,p'-DDD may be partially interfering with receptormediated uptake by binding to surface apoproteins of HDL. In this regard, it is noteworthy that adrenal imaging with radioiodinated cholesterol analogs is oftentimes
